Eli Lilly’s Visionary Approach to Alzheimer’s and Chronic Weight Management
Eli Lilly is advancing treatments in oncology, diabetes, immunology, obesity, and Alzheimer’s disease, with new therapies on the horizon. In Taiwan, Lilly is addressing growing concerns about dementia and obesity with significant R&D investment and plans to conduct over 60 clinical trials in 2024.